Susan L. Morgan
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial.
Journal: BJU international
Published: September 26, 2024
Self-regressing oral CD30-positive, EBV-negative, T-cell lymphoproliferative lesions. A poorly understood process highlighted by ominous clinicopathologic features and indolent behavior.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology
Published: March 11, 2021
Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.
Journal: Journal for immunotherapy of cancer
Published: May 26, 2020
The Impact of Centralised Services on Metric Reflecting High-quality Performance: Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre.
Journal: European urology focus
Published: April 13, 2020
Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies.
Journal: PloS one
Published: October 09, 2016
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.
Journal: Oncotarget
Published: September 08, 2015
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 10, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026